SKTO.US Sk3 Group Inc

Healthcare Drug Manufacturers - Specialty & Generic USA Stocks
- USD
Market cap
-
P/E
-
P/B
-
ROE
196.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2013.

Is SKTO.US undervalued?

Graham number

The Graham number of Sk3 Group Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sk3 Group Inc fundamental analysis

No fundamental analysis for Sk3 Group Inc yet.

Sk3 Group Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sk3 Group Inc

SK3 Group, Inc. provides management advisory, licensing, and marketing services for medical marijuana collectives in California. It licenses various products for marketing and sale, including the YAK line of medical marijuana edibles; Canna-Loz, a delivery system for large doses of phyto-cannabinoids; Yeti, a pre-roll for pain relief; and Dharmanol, a proprietary technology that extracts, stabilizes, and preserves the medicinal cannabinoids found in hemp and marijuana in the…

Full company profile